Bristol Myers’ Q3 sales dip due to generic competition of its cancer drug Moreover, Bristol Myers reported third-quarter revenue of $11.22 billion, down from $11.62 billion a year ago. October 26, 2022 16:22 IST
Kanchana TK appointed new Director General of OPPI Most recently, she was with Bristol Myers Squibb, where she was Lead – Public Affairs for Middle East, Africa and… May 30, 2016 18:29 IST
Amid patent debate, BDR Pharma and Lee Pharma give up battle to copy drugs Blames lack of government support for cheap generics and pressure from Big Pharma Drugmakers BDR Pharma and Lee Pharma have… April 14, 2016 14:00 IST
BMS, Cipla may settle patent row amicably Bristol-Myers Squibb and Cipla are heading towards an amicable settlement on a long-stretched patent row over Entecavir, a pharmaceutical combination… April 29, 2015 02:35 IST
Last DA hike in 7th Pay Commission: Central govt employees set for salary boost ahead of Diwali – Check likely increase
9 Photos Onam 2025: Colourful pookalams to delicious Sadya feasts; how India is celebrating Thiruvonam 14 hours agoSeptember 5, 2025